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I. INTRODUCTION 
Biological membranes, while responsible for separating 
compartments, are also involved in the communication of 
related information. The flow of information depends on the 
nature of the stimuli and the proteins embedded within the 
membrane. The proteins either allow transport or propagate a 
signal between compartments as defined by the system. 
Certain hormones, after binding to the exterior of cells, 
have long been known to alter the intracellular concentrations 
of cyclic AMP, calcium, cyclic GMP and inositol. These second 
messengers rapidly diffuse and elicit the cellular response. 
Signalling of the hormone bound receptor to the effector 
system that alters intracellular concentrations of second 
messenger is often times facilitated by a member of the guanyl 
nucleotide-binding (or G) protein family. This signalling 
pathway can be disrupted by ADP-ribosylation of the a-subunit 
of the stimulatory or inhibitory G-protein heterotrimeric 
complex by the enzymatic activities of cholera or pertussis 
toxin. This post-translational modification can exert varied 
responses dependent upon which G-protein is modified by which 
ADP-ribosyltransferase. 
The best described, and longest known, effector for the G-
protein coupled pathways is adenylyl cyclase, which catalyses 
the conversion of ATP to cyclic AMP. This second messenger 
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binds to and dissociates the the regulatory subunit of cAMP-
dependent protein kinase, thus activating the kinase and 
evoking a metabolic cascade. The stimulatory 6-protein, when 
stimulated by the occupied receptor, exchanges GTP for GDP, 
dissociates the GTP bound alpha subunit from the beta/gamma 
complex which then activates the adenylyl cyclase. The GTP 
bound alpha subunit, the active form, is rapidly inactivated 
when the GTP is hydrolyzed by the GTPase activity of the alpha 
subunit, thus allowing reassociation of the beta/gamma 
subunits to the alpha with return to the basal state. The 
inhibitory G-protein, when stimulated by the occupied receptor 
undergoes a similar dissociation as for the stimulatory G-
protein, however the liberated GTP-bound alpha subunit is 
thought to inhibit adenylyl cyclase. An opposing theory 
suggests that the alpha subunit of the inhibitory complex is 
inactive, and that the beta/gamma subunit complex is free to 
bind basal levels of. free stimulatory alpha. At the time of 
this writing (Spring 1990), there are 16 known G-alpha 
subunits of 4 different classes, 4 known beta subunits and 2 
known gamma subunits. The alpha subunit is considered the 
most variant and possesses the functionally active GTPase 
activity. The only assigned roles for the less variant 
beta/gamma subunits are to regulate the alpha, and provide a 
membrane anchor. While only a few of the earlier discovered 
G-proteins effect adenylyl cyclase, the more recently 
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discovered, and more abundant, alpha subunlts are found to 
effect ion channels. 
Adenosine diphosphate-ribosyltransferase catalyzes the 
transfer of ADP-ribose from nicotinamide adenine dinucleotide 
(NAD) to proteins or acceptor molecules (1,2). Mono-ADP-
ribosyltransferase, the focus' of this research, catalyzes the 
transfer of one ADP-ribose group from NAD to an acceptor 
molecule. The poly-ADP-ribosyltransferases catalyze the 
transfer of an ADP-ribose to an acidic amino acid through an 
0-glycosidic linkage followed by successive /8(1 - 3) 
polymerizations of several ADP-ribose groups. This class of 
transferase is normally associated with functions in the 
nucleus of higher eukaryotes (1,2). 
Mono-ADP-ribosyltransferase activity has been detected in 
prokaryote and eukaryote cells. The exotoxins from several 
prokaryotes possess ADP-ribosyltransferase activity with 
partially defined substrate specificities. The toxin from 
Vibrio cholera is specific for arginine or small molecular 
weight guanyl compounds. It has been used extensively as a 
tool in the elucidation of the stimulatory G-protein coupled 
effector systems. ADP-ribosylation of the alpha subunit 
inhibits its GTPase activity, thus persistently activating 
adenylyl cyclase (1). The toxin from Bordetella pertussis 
ADP-ribosylates a cysteine residue of the inhibitory G-protein 
alpha subunit, which dissociates the G-protein heterotrimer 
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from the receptor, thus interfering with the receptor coupled 
dissociation of the alpha subunlt. The net effect of ADP-
ribosylation by either toxin is persistent activation of 
adenylyl cyclase (1,2). The toxin from Corvnebacterlum 
diphtheria modifies the dipthamide residue of the ribosomal 
elongation factor 2, thus shutting of protein biosynthesis 
(1,2). The toxin from Clostridium botullnum modifies 
asparaglne of rho small molecular weight GTP-binding proteins, 
with a presently unknown physiological effect (3). 
Several types of animal cells have also been found to 
possess endogenous mono-ADP-ribosyltransferase activities 
(1,2). The physiological significance of an endogenous 
enzymatic activity resembling pathogenic toxins has puzzled 
investigators for more than a decade. It is suspected that 
the ADP-ribosyltransferase plays a role in signal 
transductional processes; however, the regulation and 
compartmentalization must be very strict to preempt 
pathological cell death. 
Moss and associates have reported the purification and 
characterization of four classes of monoADP-ribosyltransferase 
from turkey erythrocyte. Types A (4) and B (5) were purified 
from soluble fractions, type C (6) was purified from the 
peripherally associated membrane fraction, and type D (7) was 
purified from the nuclear fraction. Most of the identified 
endogenous mono-ADP-ribosyltransferases catalyze the 
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formation of N-glycosidic bonds between ADP-ribose and 
arginine (1,2). However, a cysteine specific ADP-
ribosyltransferase activity was recently identified and 
purified from human erythrocytes (8). 
Several tissues have been reported to possess an enzyme 
catalyzing the reverse reaction, ADP-ribosylhydrolase 
(9,10,11), which implies a physiological significance. 
Studies of ADP-rlbosyltransferase and ADP-ribosylhydrolase 
activities in Rhodosplrlllum rubrum (12) delineated an elegant 
regulation of the catalytic Fe iron protein center of 
nitrogenase. 
ADP-ribosyltransferase seems almost ubiquitous in its 
tissue type distribution. The activity has been detected in 
turkey erythrocyte, rat liver, Xenopus laevis liver, lung, 
muscle, heart and erythrocyte, bovine thyroid, bovine, porcine 
and rabbit skeletal muscle. Torpedo synaptosomes, rat Islets 
of Langerhans, adipocyte plasma membranes (1) and human 
platelets (13). 
Soman and associates detected (14) and partially 
characterized the endogenous mono-ADP-ribosyltransferase 
activity in skeletal muscle sarcoplasmic reticulum of rabbit 
and sarcolemma of pig (15). 
The purification of the integral membrane mono-ADP-
ribosyltransf erase has been of primary interest to 
characterize and eventually establish a metabolic role for 
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this interesting enzyme. 
This dissertation describes the first purification of the 
mammalian integral membrane mono-ADP-ribosyltransferase and 
its partial characterization. The purification is a rapid 
method that requires only 3 days from start to finish. 
Positive identification of the mono-ADP-ribosyltransferase was 
confirmed by a characterized zymographic localization and HPLC 
assay of gel slice incubations. 
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II. MATERIALS AMD METHODS 
A. Materials Used 
Frozen maturè rabbit skeletal muscle was purchased from 
Pel-Freeze Biologies, DE-52 was purchased from Whatman, 
Toyopearl DEAE was purchased from Supelco, Triton X-100 was 
obtained from Boehringer-Mannheim, the silver stain kit, SEC-
250 size exclusion column and molecular weight markers were 
from Bio-Rad. The molecular weight markers had resolved 
masses of: phosphorylase b, 97,400 Da; bovine serum albumin, 
66,200 Da; ovalbumin, 42,699 Da; and carbonic anhydrase, 
31,000 Da.. BCA Protein Assay kits (standard and micro) and 
OPA reagent were purchased from Pierce Chemical Company, 3-
methoxybenzamide was purchased from Aldrich, [P-32] NAD was 
purchased from ICN, Centricon 30 microconcentrators were 
purchased from The Amicon Company. Remaining reagents and 
chemicals were obtained from the Sigma Chemical Company. 
B. Methods 
Arginine specific mono-ADP-ribosyltransferase was 
determined by the use of three assays. 
1. L-aralnlne methvl eater assay 
An arginine methyl ester HPLC assay using precolumn OPA 
derivatization and postcolumn fluorescence detection was as 
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described in (16). Briefly, the reaction mixture contained 50 
mM potassium phosphate, pH 7.0, 10 mH L-arginine methyl ester 
(LAME), and 2 mM NAD in a total volume of 100 uL. Reactions 
were Initiated by addition of enzyme at a linear dilution and 
incubated at 30oC for the indicated amount of time in the 
linear range. The HPLC system consisted of two Beckiaan model 
llOA pumps with a 421 gradient programmer. Solvent A = 50 mM 
potassium phosphate, pH 4.0, and solvent B = 5% THF/95% MeOH. 
An aliquot of the reaction mixture was derivatized. with an 
equal volume of OPA/B-mercaptoethanol reagent for 1 minute and 
injected onto a C-8 reversed phase column at a flow rate of 
1.5 ml/min. The gradient conditions were 5% - 100% B in 5 
min. OPA products were detected with a Kratos FS950 
Fluorometer with an excitation wavelength of 365 nm and an 
emission wavelength of 418 nm. Total analysis time for each 
sample was 15 min with ADP-ribosylated LAME eluting at 3.9 
min. Conversion rates were determined by peak height analysis 
and comparison made to ADP-ribosylated LAME standard curves. 
Typically, the assay calculations included the dilution 
factors multiplied by 79 pmole ADP-ribosylated LAME per mm 
peak height. In all assays, the values represent those 
obtained in the linear dilution range and at linear incubation 
times. Bovine serum albumin was added (0.05 mg/ ml) to 
stabilize the enzyme in those fractions with dilute protein 
concentrations. 
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2. Guanylhvdrazone assay 
The guanylhydrazone diethylamino-(benzylidine-
amino)guanidine (DEA-BAG) HPLC assay was as described 
previously (15,17,18) with some modifications. The enzyme was 
incubated in 2 mM DEA-BAG, 10 mM NAD, 100 mM phosphate buffer 
for 1 h at 30*0. The reactions were stopped with an equal 
volume of 20% trichloroacetic acid, centrifuged and stored for 
up to 2 weeks at -20*C. The HPLC system consisted of two 
Beckman pumps (models lOOA and llOA) with a 420 gradient 
programmer, a Beckman 165 variable wavelength detector and a 
Nelson Analytical 760 Series Interface to an IBM PC for data 
analysis. Solvent A = 0.2 M triethylammonium acetate, 0.1 M 
sodium perchlorate, pH 6.0, and solvent B = methanol. An 
aliquot of the stopped reaction mixture was injected onto a C-
18 (5 nm) reverse-phase column at a flow rate of 1 ml/min. 
Gradient conditions were 0 - 50% B in 1 min and held at 50% 
for 25 min. Total analysis time was 25 min, with the anomeric 
ADP-ribosylated DEA-BAG products eluting at 16 and 17 min. 
Conversion rates were determined by integration. One unit was 
defined as 1 pmole DEA-BAG converted per min. 
3. Zvmoaraphic in situ gel assay 
The symographic polyacrylamide in situ gel assay was 
essentially as described previously (19) but with the 
inclusion of 1 mM ADP-ribose at a 10-fold molar excess to NAD 
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to eliminate nonenzymatic reactions. Prior to 
electrophoresis, protein samples were precipitated from 
detergent and lipid contaminants as described previously (20) 
to prevent smearing during electrophoresis. Briefly, 30 
volumes ethanol : acetone (1:1) were mixed with 50 /til sample 
with variable protein concentrations, chilled to -20'C for at 
least 1 h, centrifuged, and the supernatants discarded. 
Residual solvent was removed in a Speed-Vac. Our studies 
displayed 96% recovery of protein (data not shown). 
Delipidated samples were incubated in 1% sodium dodecyl 
sulfate, 10 % glycerol, 0.005% bromophenyl blue and 50 mM 
Tris-HCl, pH 6.8, for 5 min at room temperature. Samples were 
electrophoresed according to (21) in 10% acrylamide mini gels 
(0.75 X 60 X 80 mm) for 30 min at 200 V. Electrophoretic 
times greater than 1 h destroyed enzymatic activity. The ADP-
ribosyltransferase was renatured by incubating the gel in 20 
volumes of 2.5% Triton X-100 for two cycles of 0.5 h and one 
cycle in water for 0.5 h. The gel was transferred to a heat-
sealing plastic bag and incubated in two volumes 100 mM 
phosphate, pH 7.5, 1 mM dithiothreitol, 400 mM NaCl, 2 mg/ml 
histone (Sigma, Type VIIIs), 1 mM ADP-ribose, and 100 uM [P-
32] NAD (100 cpm/pmol) for up to 4 h at room temperature. The 
reactions were stopped in 50% TCA, 0.1 % Coomassie blue. The 
gels were destained in 7% acetic acid/30% methanol until the 
background was cleared. The gels were also silver-stained 
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according to the BioRad instructions, dried and exposed to X-
OMAT autoradiography film in the presence of intensifying 
screens. The molecular mass determination for the enzyme was 
made by comparison of the relative mobility of the enzyme with 
those of the molecular weight markers on graph of the log 
molecular mass versus relative mobility. Alignment of the 
bands with the appropriate size was' confirmed by running 
carbonic anhydrase in an adjacent lane. 
4. Buffers used 
Homogenization buffer (Buffer A) was 10 mM histidine, 10% 
sucrose, 1 mM benzamidine, 1 mM EDTA, 1 mM iodoacetamide, 77 
nM aprotonin, 0.7 juM pepstatin, 1.1 /iM leupeptin, 0.23 mM 
phenylmethylsulfonylfluoride (pH 7.0). The KCl wash buffer 
(Buffer B) was 0.6 M KCl, 10 mM histidine, 1 mM benzamidine, 1 
mM EDTA, 1 mM iodoacetamide, 77 nM aprotonin, 0.7 nK 
pepstatin, 1.1 fM leupeptin, 0.23 mM phenylmethyIsulfony1-
fluoride (pH 7.0). The propylene glycol wash buffer (Buffer C) 
was 20% propylene glycol, 50 mM Tris, 0.1% Triton X-100, 1 mM 
benzamidine, 1 mM EDTA, 1 mM iodoacetamide, 77 nM aprotonin, 
0.7 mm pepstatin, 1.1 iM leupeptin, 0.23 mMphenylmethylsulf-
onylfluoride (pH 7.5). DE-52 buffer (Buffer D) was 10 mM 
phosphate, 10% glycerol, 0.05% sodium deoxycholate, 1 mM 
benzamidine, 1 mM EDTA (pH 7.5). Affinity buffer (Buffer E) 
was 50 mM Tris, 0.5% polyoxyethylene-9-lauryl ether, 0.2 M 
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NaCl (pH 7.5). Size exclusion chromatography buffer was 50 % 
ethylene glycol, 100 mM phosphate, pH 7.0. 
5. Preparation of sfceletal muscle nicroaomes 
Microsomal membrane was prepared by a method modified from 
previously described methods (22,23). All steps were 
performed at 4*c. Mature rabbit skeletal muscle (0.5 kg) was 
thawed, passed through a meat grinder, and homogenized in 1.4 
liters of Buffer A at high speed for 1 min in a commercial 
size Waring Blendor. The homogenate was centrifuged at 15,000 
X g for 0.5 h, filtered through glass wool and centrifuged at 
100,000 X g for 2 h. The pellet was resuspended and 
homogenized with a hand held tissue grinder in Buffer B (150 
ml), stirred for 1 h, and centrifuged at 100,000 x g for 1 h. 
The pellet was resuspended and homogenized in Buffer C (50 
ml), stirred for 1.5 h and centrifuged at 105,000 x g for 3 h. 
The final pellet was resuspended in Buffer A (30 ml or > 10 
mg/ml) and called lOOK x g pellet. Protein concentration was 
determined prior to the solubilization step. 
6. Synthesis of inhibitor affinity column 
3-aminobenzamide agarose was prepared by a modification of 
a described method (24). 3-aminobenzamide was succinylated 
with succinic acid anhydride with a 95% yield after hot 
ethanol washes. Positive FAB mass spectrometry confirmed the 
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presence of one major molecular ion of 237.1, which conforms 
to the 236 Da molecular weight of succinylated 3-
aminobenzamide. The molar extinction coefficient at 318 nm 
was estimated to be 1247 cm-l M-1. A linker 3,3'-
iminobispropylamine was coupled to CNBr activated agarose at 
pH 10 -11 in 100 mM phosphate and fluorescamine analysis (25) 
determined the spacer arm concentration to be about 48 mM. 
Final coupling was achieved by dissolving 1 g succinylated 3-
aminobenzamide (4 mmole) in 20 ml dimethylformamide followed 
by the addition of 2.5 ml derivatized agarose in 5 ml H20 and 
0.769 g (4 mmole) l-ethyl-3-(3-methylaminopropyl)carbodi-
imide (26) dissolved in 5 ml 0.5 M phosphate at pH 5. 
Spectral scanning of a 10% suspension of the derivatized 
agarose in 10% glycerol, 10 mM phosphate buffer, pH 7.5, 
indicated a maxima at 288 nm and a ligand density of 12 mM. 
7. Time course of zvmoaraphic reaction 
Muscle mono-ADP-ribosyltransferase, 100 jug (concanavalin 
A eluate, 293,000 U/mg) was precipitated with 30 volumes 
ethanol:acetone, (1:1), centrifuged and the pellet 
lyophilized. The pellet was dissolved in 130 /xl 1% SDS, 50 % 
glycerol, 50 mM Tris, 0.005 % bromophenyl blue, pH 6.8 and 
incubated for 5 min at 30*C. Fifteen /il was added to each of 
8 wells of an analytical mini-gel (10 % aery1amide, 0.75mm X 
60mm X 80mm) and electrophoresed for 30 min at 200 V. The gel 
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was renatured in 2.5 % Triton X-100 as described previously 
and 8 gel slices were removed from the 38 - 39 kDa region of 
each of the lanes. The gel slices were equilibrated 
for 5 min in 2 ml zymographic buffer containing all of the 
components except NAD. At time zero, 100 /kM NAD [P-32], 100 
cpm/pmole, was added and the incubation carried out at room 
temperature. At times 0, 15, 30, 90, 120, 180 and 240 min, a 
gel slice was transferred to a labeled vial containing 50 % 
TCA 0.1 % coomassie blue, fixed for 1 h followed by extensive 
washing with 30 % Methanol, 7 % acetic acid un-til the gel 
slices were clarified. Cerenkov counting of the slices was 
performed and the values tabulated. 
8. Hvdroxvlamine sensitivity 
Hydroxylamine sensitivity reactions were done similar to 
those described by Hsia et al. (27) . To 250 /Kg of mono-ADP-
ribosyltransferase (concanavalin A elute, 170,000 U/mg) was 
added 5 ml ethanol: acetone (1:1). The mixture was cooled, 
centrifuged, the supernatant decanted and the precipitate 
lyophilized. This delipidated and detergent free precipitate 
accounted for about 96% of the membrane protein. The dried 
protein was dissolved in 200 fil 1% SDS, 10 % glycerol, 50 mM 
Tris, 0.005% bromophenyl blue (pH 6.8), incubated for 5 min 
and applied to a preparative mini-gel (10 % acrylamide, 1mm 
X 60mm X 80 mm), electrophoresed and carried through the 
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zymographic reaction as described previously except with 1000 
cpm/pmole [P-32] NAD. The autoADP-ribosylated monoADP-
ribosyltransferase was electroeluted from the 38 - 39 kDa 
region of the gel and concentrated with a centricon 30 to 100 
Ml* Protein recovery was 25 ng (10 %). The sample was 
aliguoted into two tubes, each containing 10 ng protein (250 
pmole) and about 2000 cpm [P-32] (20 pmole ADP-ribose), 
precipitated with 30 volumes ethanol:acetone (1:1) and dried. 
To each tube was added 250 nl of either 0.5 M hydroxylamine, 
1 % SDS, 50 mM HEPES, pH 7.5, or 0.5M NaCl, 1% SDS, 50 mM 
HEPES, pH 7.5, and incubated at 37oC. At times 0, 60, 90 and 
120 minutes, 50 fil (2 jig) was removed from the incubations and 
added to 200 jul 20% cold TCA and the precipitates collected by 
centrifugation. The pellets were dissolved in 2% SDS, 50 % 
glycerol, 50 mM Tris, 0.005 % bromophenyl blue (pH 6.8), 
applied to an analytical mini-gel (10% acrylamide, 0.75mm x 
60mm X 80mm), electrophoresed, fixed with 50 % TCA, 0.1 % 
coomassie, washed with 30 % methanol, 7 % acetic acid, dried 
and exposed to X-Omat film in the presence of intensifying 
screens. Several densitometry scans of each lane provided a 
unitless value ,for graphical representation. Cerenkov 
counting of the pellets post hydroxylamine or NaCl and prior 
to electrophoresis (data not shown) gave values closely 
resembling those obtained from densitometry. 
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9. 3-aminobenz&mide Inhibition of zvmoaraphv 
Muscle mono-ADP-ribosyltransferase, 60 fig (concanavalin A 
eluate, 293,000 U/mg) was precipitated with 30 volumes 
ethanol:acetone, (1:1), centrifuged and the pellet 
lyophilized. The dry pellet was dissolved in 80 /kI 1% SDS, 50 
% glycerol, 50 mM Tris, 0.005 % bromophenyl blue, pH 6.8 and 
incubated for 5 min at 30*C. Fifteen fil was added to each of 
5 wells of an analytical mini-gel (10 % acrylamide, 0.75mm X 
60mm X 80mm) and electrophoresed for 30 min at 200 V. After 
electrophoresis, the gel was renatured in 2.5 % Triton X-100 
as described previously. Five gel slices were removed from 
the 38 - 39 kDa region of each of the lanes and one slice 
transferred to scintillation vials each containing 2 ml 
zymographic reaction components as described previously and 0 
to 20 mM 3-aminobenzamide. The reactions were allowed to 
proceed for 4 h, followed by fixing in 50 % TCA, 0.1 % 
coomassie blue and washing with 30 % methanol, 7% acetic acid 
to clarity and Cerenkov counting. A Dixon-Webb plot was 
prepared by plotting 1/cpm P-32. labeled 38.5 kDa protein vs 
inhibitor concentration. 
10. Histone stimulation of zvmoaraphic reaction 
Muscle mono-ADP-ribosyltransferase, 100 f ig  (concanavalin 
A eluate, 293,000 U/mg) was precipitated with 30 volumes 
ethanol:acetone, (1:1), centrifuged and the pellet 
17 
lyophlllzed. The dry pellet was dissolved in 130 nl 1% SDS, 
50 % glycerol, 0.005 % bromophenyl blue, pH 6.8 and incubated 
for 5 min at 30*C. Fifteen (il was added to each of 8 wells of 
an analytical mini-gel (10 % acrylamide, 0.75mm X 60mm X 80mm) 
and electrophoresed for 30 min at 200 V. The gel was 
renatured in 2.5 % Triton X-100 as described previously and 8 
gel slices were removed from the 38 - 39 kDa region of each of 
the lanes. The slices were equilibrated for 5 min in 
scintillation vials containing 2 ml zymographic reaction 
components with 0, 10, 20, 40, 80, 160, 320 and 480 tig/ml 
histone (Sigma, type VIIIs). The reactions were allowed to 
proceed for 4 h, followed by fixing, washing to clarity and 
Cerenkov counting. 
11. Determination of auto-ADP-ribosvlation 
Muscle mono-ADP-ribosyltransferase, 60 ng (concanavalin A 
eluate, 293,000 U/mg) was precipitated with 30 volumes 
ethanol:acetone, (1:1), centrifuged and the pellet 
lyophilized. The dry pellet was dissolved in 80 nl 1% SDS, 50 
% glycerol, 0.005 % bromophenyl blue, pH 6.8 and incubated for 
5 min at 30'C. Fifteen fxl was added to each of 5 wells of an 
analytical mini-gel (10 % acrylamide, 0.75mm X 60mm X 80mm) 
and electrophoresed for 30 min at 200 V. After 
electrophoresis, the gel was renatured in 2.5 % Triton X-100 
as described previously. Five gel slices were removed from the 
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scintillation vial with the zymographic reaction components 
including 2 mg/ml histone (Sigma type VIIIs) and allowed to 
react for 4 h, followed by fixing in 50 % tCA, 0.1 % coomassie 
blue and washing to clarity in 30 % methanol, 7 % acetic acid. 
The gel slices were electroeluted and the sample concentrated. 
Eighteen micro-grams of protein was recovered in the 
electroeluted sample. To an analytical mini-gel (0.75mm x 
60mm X 80mm) was applied 6 electroeluted protein and 5 ng 
histone (Sigma, type VIIIs) in separate lanes dissolved in 1 % 
SDS, 50 % glycerol, 50 mM Tris, 0.005 % bromophenyl blue, pH 
6.8. The samples were electrophoresed for 30 min at 200 V, 
fixed in 50 % TCA, 0.1 % coomassie blue and destained in 30 % 
methanol, 7 % acetic acid, dried and exposed to X-OMAT film 
with intensifying screens. 
12. Comparison of cholera toxin and muscle transferase 
Cholera toxin A Sigma, 6 and 12 /xg, 22,000 U/mg) was 
diluted in sample buffer to provide final concentrations of 
1 ng/nl toxin, 1% SDS, 50 % glycerol, 50 mM Tris, 0.005 % 
bromophenyl blue pH 6.8 with or without 2.5 % B-
mercaptoethanol. Muscle mono-ADP-ribosyltransferase 
(concanavalin A eluate, 40 ng, 150,000 U/mg) was precipitated 
with ethanol:acetone (1:1), centrifuged, the pellet 
lyophilized and dissolved in sample buffer to provide final 
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concentrations of 2 jitg protein/#l, 1 % SDS, 50 % glycerol, 
0.005 % bromophenyl blue, pH 6.8, with or without 2.5 % B-
mercaptoethanol. After 5 min preincubation, the samples were 
electrophoresed and carried through the zymographic assay as 
described previously. 
13. Gal-alice incubation with auanylhvdrazone 
Ten Ml Mono-ADP-ribosyltransferase (concanavalin A eluate, 
5.4 ng protein, 172,000 U/ml, 320,000 U/mg) was precipitated 
with 30 volumes ethanol:acetone (1:1), centrifuged, the 
supernatant decanted and the pellet lyophilized. Twenty ul of 
1 % SDS, 50 mM Tris, 50 % glycerol, 0.005% bromophenyl blue, 
pH 6.8, was added and the sample electrophoresed in a mini-
gel (10% acrylamide, 0.75mm X 60mm X 80mm) for 30 min at 200 V 
with prestained molecular weight markers as reference. At the 
end of the electrophoresis, the gel was renatured by 
incubation with 20 volumes 2.5 % Triton X-100 for two cycles 
of 30 min each followed by one cycle in water for 30 min. The 
gel slices from the 38,500 Da region were cut from the gel and 
diced (not minced) to 0.75 mm cubes with a sharp razor, and 
transferred to an assay mixture containing 100 mM potassium 
phosphate, pH 7.5, 10 mM NAD, 2 mM DEA-BAG in a final volume 
of 300 fil. Incubations were conducted at 30'C with frequent 
agitation. At times 0, 2 and 4 h, 90 /xl aliquots were removed 
and added to 150 jul 20 % TCA. The stopped reactions were 
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analyzed for ADP-ribosylatéd DEA-BAG in the HPLC assay as 
previously described. 
14. ADP-ribosvlhvdrolase reaction 
ADP-ribosylhydrolase from rat skeletal muscle, was 
partially purified from fresh rat skeletal muscle as 
previously described (28). Muscle (375 g) was homogenized in 
1 L buffer P (20 mM potassium phosphate, 1 mM EDTA pH 7.5), 
centrifuged at 1500 x g for 30 min followed by centrifugation 
of the glass wool filtered supernatant at 45,000 x g for 60 
min. The supernatant was (800 ml) was applied to a DE-52 
column, equilibrated in buffer P and washed with the same 
buffer. The ADP-ribosylhydrolase activity was eluted at 0.5 M 
NaCl in buffer P (440 ml) and applied to a phenyl-Sepharose 
C1-4B column equilibrated with 0.5 M NaCl in buffer P, and 
washed with the same buffer. ADP-ribosylhydrolase activity 
was eluted with 50 % propylene glycol in buffer P (170 ml) and 
applied to a hydroxylapatite column followed by elution with a 
linear gradient of 20 to 500 mM potassium phosphate in 20 % 
propylene glycol, 1 mM EDTA, pH 7.5. The eluant containing 
ADP-ribosylhydrolase activity (102 ml) was desalted on a 
Sephadex G-25 column and applied to a DE-52 column which was 
equilibrated with buffer P. The ADP-ribosylhydrolase activity 
was eluted in a linear gradient of 0 to 300 mM NaCl in buffer 
P, dialyzed against buffer P and used for enzymatic studies 
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(74 ml, 79 fold purification, 2886 U/ml, 493 U/mg). One unit 
of ADP-ribosylhydrolase was defined as that amount of enzyme 
required to convert 1 nmole of ADP-ribose DABSYL-arginine 
methyl ester per min in a HPLC assay (28). Three reactions 
were carried out containing ADP-ribosyltransferase and ADP-
ribosylhydrolase, ADP-ribosyltransferase alone or ADP-
ribosylhydrolase alone. ADP-ribosyltransferase, 1600 U (Con A 
eluant, 12 ng, 160,000 U/ml, 133,000 U/mg). was incubated with 
2.5 U ADP-ribosylhydrolase (DE-52 eluant II, 5 /xg 74 U/ml, 493 
U/mg). The incubations were conducted in 10 mM phosphate 
buffer, 15 mM MgCl, and 5 mM dithiothreitol in a total volume 
of 50 fil for 1 h at 30'C, Reactions were stopped by the 
addition of 1.5 ml.ethanol: acetone (1:1), chilled, 
centrifuged, the supernatants discarded and the pellets 
lyophilized. The protein pellets were dissolved in 1 % SDS, 
50 % glycerol, 50 mM Tris, 0.005 % bromophenyl blue, pH 6.8, 
electrophoresed and carried through the zymographic assay as 
previously described. The gel was dried, exposed to X-OMAT 
film in the presence of intensifying screens. After exposure 
to film, the bands were cut out of the gel and counted by 
Cerenkov spectrometry. 
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XII. RESULTS 
A. Purlfloatlon 
1. solubilization with aodltun deoxvoholat# 
Sodium deoxycholate (DOC) released an abundant amount of 
ADP-ribosyltransferase activity into the soluble phase. 
Several concentrations of deoxycholate were analyzed to 
determine the optimum concentration for ADP-ribosyltransferase 
solubilization (data not shown). The concentration of 0.3% 
sodium deoxycholate (w/v at a protein concentration of 10 
mg/ml) provided the maximum amount of solubilization without 
rapid denaturation. To the lOOK x g pellet, enough sodium 
deoxycholate was dissolved in buffer A to provide a 
0.3 % (w/v) concentration of detergent with a 10 mg/ml final 
concentration of protein. The mixture was stirred at 4'C for 
0.5 h and centrifuged at 100,000 x g for 1.5 h at 4*C. The 
opalescent supernatant was removed with a pipet and the light 
sediment and pellet were discarded. Typical preps yielded 
60 - 80 ml containing 6 mg/ml protein. Due to the rapid half-
life of the enzyme in 0.3% DOC (about 1 day at 4'C) the DE-52 
step was done immediately after solubilization. 
2. DB-52 cellulose chromatography 
A panel of columns was screened to assess retention and 
elution of the deoxycholate solubilized ADP-ribosyltransferase 
activity. The activity did not bind to cation exchangers but 
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was retained on DEAE sepharose and Toyopearl DEAE and DE-52 
cellulose anion exchangers as measured by the lack of or low 
levels of activity in the fall-through fractions. The yields 
of enzyme eluted in gradients from 0 to 1 M KCl were « 4% for 
DEAE cellulose, «2 % for Toyopearl DEAE and « 60 - 70% for DE-
52. Because of the anionic nature of deoxycholate, a more 
complete elution from the anion exchangers was explored by 
dialyzing the deoxycholate extract with several nonionic 
detergents preceding chromatography. In all instances, 
including DE-52, all or most of the activity was found in the 
fall-through fractions (data not shown). Loading of DE-52 in 
the presence of DOC and switching to Lubrol PX resulted in 
immediate nonselective elution of the monoADP-ribosyltransfer­
ase activity. Concentrations as low as 0.05% DOC were 
sufficient to retain the activity on the anion exchanger. 
DE-52 microgranular anion exchange cellulose (Whatman), was 
converted to the chloride form and used once, then discarded. 
The DE-52 was equilibrated and degassed in buffer D before 
pouring, packing, and washing of the column with 5 additional 
volumes of buffer D. 
The column was run at room temperature by loading 
approximately 160 mg 0.3% DOC solubilized membrane protein in 
26 ml buffer A onto a 2.5 X 16 cm (80 ml) DE-52 column at a 
flow rate of 2 ml/min and eluted with 0 - 1 M KCl in buffer D 
over 500 ml (figure 1). A positive flow rate was maintained 
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at 2 ml/min with a peristaltic pump. The protein elution 
profile was monitored by an ISCO in-line UV detector. Sixty 
fractions of 8 ml each were assayed for ADP-ribosyltransfer­
ase activity and the pool made with those fractions containing 
the highest ADP-ribosyltransferase activity. Assays were done 
with 20 ul of each fraction, 10 mM LAME, 2 mM NAD and 50 mM 
potassium phosphate, pH 7.0. Typical preps yielded 40 - 50 ml 
containing 0.5 mg/ml protein. Protein loads of solubilized 
membrane protein above 2 mg per ml column volume overloaded 
the column and greater than 50% of the activity was found in 
the fall-through fractions. 
Figure 1 shows the elution profile of ADP-ribosyltrans­
ferase activity from the DE-52 column. The enzymatic activity 
is represented by the dashed peak and a conservative pool of 
the activity was made from fractions with specific activities 
over 1000 U/ml. This column has been repeated up to 15 times 
with essentially the same profile at room temperature. If the 
DE-52 column step was performed at 4'C,. resolution was lost, 
and the activity was spread over many fractions. 
3. Concanavalin A agarose chromatography 
Concanavalin A agarose (Sigma Chemical Co.) was found to 
bind 100% of the mono-ADP-ribosyltransferase activity from the 
DE-52 pool. The presence of 0.05% DOC did not interfere with 
concanavalin A binding. 
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Figure l. DE-52 chromatography profile. The ADP-ribosyl-
transferase activity elution is indicated by the 
dashed line in Units/ml where 1 U is 
defined as that amount of enzyme required to 
convert 1 pmole LAME per min. The KCl gradient 
is shown with Details are given in 
"Methods." 
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Wheat germ agglutinin did not bind the activity (data not 
shown). Figure 2 shows the elution profile of a 2 ml 
concanavalin A agarose column loaded with a 50 ml pool from 
the DE-52 pool, followed by washing with 20 ml buffer E (W) 
followed by elution (E) with 10 ml 0.3 M methylmannopyranoslde 
In buffer E. One ml fractions were assayed for protein 
concentration and ADP-ribosyltransferase activity by the LAME 
HPLC assay. Dilution factors of 10 for the fall through and 
washes and 50 for the eluant were used for screening the 
column and pooling the activity. Typically, the combined 
pools from two DE-52 column runs (80 - 100 ml) were passed 
twice through a 1.5 X 1.7 cm (3 ml) concanavalin A agarose 
column at a flow rate of 2 ml/min. No ADP-ribosyltransferase 
activity was found in the fall-through fraction. The column 
was washed with 10 volumes buffer E and equilibrated in two 
volumes elution buffer (0.3M methylmannopyranoslde in buffer 
E) for 12 h at A'C prior to elutioh. Elution was completed 
with an additional 3 volumes of elution buffer. 
The enzymatic activity in elution buffer was reduced in 
methyl-mannopyranoside concentration to less than 0.01 M by 
concentration in Centricon 30 microconcentràtors to a volume 
of 0.5 ml, followed by subsequent addition and concentration 
in buffer E to a volume of about 1 ml. This was necessary to 
reduce the interference in the protein assay and subsequent 
chromatography step. At this stage of the purification, the 
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enzyme was stored at -20*C for up to 4 weeks without any 
appreciable loss of activity. The concanavalin A agarose was 
washed and recycled with either 20 volumes Buffer E alone or 
Buffer E containing 0.3 H methylmannopyranoside for up to 10 
times. 
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Figure 2. Concanavalin A agarose chromatography profile. 
The.ADP-ribosyltransferase activity elution is 
indicated by the dashed line in Units/ml 
where 1 U is that amount of enzyme required to 
convert 1 pmole LAME per min. Details are given in 
"Methods." 
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4. 3-ainlnobengainlde agarose chromatography 
The concanavalin A agarose eluate, when applied to the 3-
aminobenzamide agarose column resolved two molecular weight 
forms of the monoADP-ribosyltransferase as described later in 
the "Results" section. Typically 1.0 to 1.5 ml concanavalin A 
agarose eluant fractions containing 600,000 -1,000,000 U were 
applied to 2 ml 3-aminobenzamide agarose column equilibrated 
in buffer E. The con A eluate was allowed to equilibrate with 
the column overnight at 4 C. After eluting the unbound 
fraction (3ABA fall through), the column was rinsed with 5 
volumes buffer E. The column was then equilibrated with 25 mM 
3-methoxybenzamide for 1 h prior to elution of the activity. 
One ml fractions were assayed for protein using the micro BCA 
(Pierce) kit and LAME enzymatic activity determined at a 
dilution factor of 100. Eighty % of the activity was found in 
the fall through fraction, 15% was eluted with 25 mM 3-
methoxybenzamide in buffer E, and the remainder of the 
activity was recovered in the regeneration step with 2 M KCl 
in buffer E. The 3-methoxybenzamide elution ligand, a known 
inhibitor of ADP-ribosyltransferase was removed by successive 
dilution and concentration in buffer E with centricon 30 
microconcentrators (Amicon). The active enzyme eluted with 3-
meth-oxybenzamide was > 95 % homogeneous as determined by 
silver-stained electrophoretic gels. 
Figure 3 is a 3-aminobenzamide column profile. 
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Concanavalln A agarose eluant, 1.3 ml (285,000 U ) was applied 
to a 2 ml 3-amlnobenzamlde column and reapplied a total of 4 
times. The column was washed (W) with 10 ml buffer E followed 
by elutlon with 10 ml 25 mM 3-methoxybenzamlde (E) in buffer E 
and 10 ml regeneration buffer (R) 2 M KCl in buffer E Close to 
80 % of the mono-ADP-rlbosyltransferase activity in the 
concanavalln A eluant did not bind to the 3-amlnobenzamide 
column. That which did bind was subsequently eluted, 
characterized and described later. 
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Figure 3. 3-aminobenzamide agarose column profile. The 
eluted ADP-rlbosyltransferase is depicted with the 
dashed line (-»•—•). The wash step is shown with 
(W), the elutlon step (E) and the regeneration step 
with (R). Details are given in the text. 
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If the llgand density of the 3-aminobenzamlde on the 
agarose was less than 6 mM, binding of the a form did not 
occur. To assure maximal binding, all of the coupling 
reactions must be done at buffered pH ranges as described In 
"Methods." 
5 Size exclusion chromatography 
The enzyme activity found In the 3-amlnobenzamlde fall 
through fraction was exchanged Into 50% ethylene glycol, 100 
mM phosphate, pH 7.0 by spin dialysis (centrlcon 30) and up to 
100 ug protein In 200 ul buffer was Injected Into a 600 x 7.5 
mm SEC-250 size exclusion HPLC column. The equilibration and 
Isocratlc running buffer was 50% ethylene glycol, 100 mM 
phosphate, pH 7.0. At a flow rate of 0.25 ml/mln, 1 ml 
fractions were collected and assayed with the LAME-HPLC assay 
at a dilution factor of 10. 
Figure 4 Is a SEC-250 column profile. The first peak of 
activity (12 - 15 ml) Is the break-through fraction containing 
a mixture of proteins. The peak of activity eluting at 20 -
21 ml was found to contain nearly pure ADP-rlbosyltransferase 
with a silvef-staining band at 38,500 Da and a specific 
activity of 6 um/min/mg. All fractions with activity were 
pooled separately, concentrated in Centrlcon 30 mlcroconcen-
trators and frozen without loss of appreciable activity for up 
to 4 weeks prior to use. 
31 
0.8 
0.7 
R 0-6 
CM 
«0 0.5 
1  I 0.4 
I  03 
0.2 
0.1 
1 
1 
1 
1 
- 1 
N 
II 
11 
II 
II 
II 
m II 
II 
1 1 
1 1,1 
" 1 ill 
1 ill 
1 llll 
\ 'lu 
i-r-i-i- 1 1 1 1 1 1 1 1 > 1*^ 
10 15 
Elution volume (ml) 
20 
50 
45 
40 
35 
30 
25 
20 
15 
10 
25 
% 
X 
1 
c 
3 
Figure 4. SEG-250 size exclusion column profile. The elution 
of ADP-ribosyltransferase activity is depicted with 
the dashed line. The activity eluting at 20 - 21 
ml was the highly purified fraction. 
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6. Quantitative summary of the Burlfleation 
Table 1 is a quantitative summary of the steps of 
purification. The recovery of the pure a-form of the enzyme 
was 2.0 % with about 200-fold purification. The specific 
activity of ADP-ribosyltransferase type a (1,900,000 U/mg) was 
about 82 times that for cholera toxin A, 23,100 U/mg. The B-
form of ADP-ribosyltransferase was purified to > 80% 
homogeneity with a 2.1 % yield to a specific activity of about 
6,000,000 U/mg, which is about 3 times higher than the 
specific activity of the a-form of the enzyme. The 
purification values are relative to the 100 K x g microsomal 
membrane fraction because of the consistent linear activity 
with activity assays at various dilutions and times. While 
activity is detectable in the 15 K x g supernatant, there 
appear to be factors that interfere with the assay. 
Generally, the activity in the 100 K x g pellet (microsome) 
had 10 - 70 fold higher specific activities than the 15 K x g 
supernatant. 
Units were expressed as pmol LAME converted per min as 
determined with the LAME HPLC assay as described in 
"Experimental Methods." All initial velocities were 
determined at linear dilution and time. Incubation assays 
included 10 mM LAME, 5 mM NAD, 0.1 mg/ml bovine serum albumin, 
50 mM phosphate pH 7.0 and the following enzyme fraction 
protein concentrations. 
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TABLE 1. Quantitative summary of the purification 
STEP* VOLUME U/ML UNITS %YIELD PROTEIN U/MG PURIF 
(ml) XlO"^ (total) (mg/ml) xio"6 X-fol( 
1) 15K X g 1040 0.002 
D 
2.28 - 17 0.00013 -
2) lOOK X g 24 0.457 10.96 100 49 0.0093 1 
3) DOC sol 104 0.105 10.90 99 4 0.026 2.7 
4) DE-52 86 0.0516 4.44 40 0.5 0.103 11 
5) Con A 2.4 1.58 3.8 35 0.31 5.1 547 
6) type a 0.62 0.389 0.23 2 0.2 1.94 207 
7) 3ABA FT 1.34 1.7 2.28 21 0.3 5.6 600 
8) type 8 0.20 1.2 0.2 2 0.2 6.0 645 
^ step 1,  15,000 X g filtered supernatant, 3.4 mg/ml; 
Step 2, 100,000 X g pellet suspension, 1.2 mg/ml; 
Step 3, 0.3% deoxycholate solubilized enzyme, 0.10 mg/ml; 
Step 4, DE-52 pool, 0.013 mg/ml; Step 5, concanavalin A 
agarose eluant, 3.0 /xg/ml; Step 6, 3-aminobenzamide agarose 
eluant (type a), 3 Mg/ml; Step 7, 3-aminobenzamide agarose 
fall through, 1.5 ug/ml; Step 8, size exclusion HPLC fraction 
(20 - 21 ml) (type fi), 1 /ig/ml. 
b 
Total units lower than that for 100 K x g attributed to 
interference in the assay with the 15 K x g supernatant. 
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7. Qualitative summary of the purification 
The SDS-PAGE protein profiles of the various stages of the 
purification are shown in Figure 5. Lane 6 shows the 
purified muscle membrane ADP-ribosyltransferase. SDS-PAGE 
visualized by silver-staining demonstrated that muscle 
membrane mono-ADP-ribosyltransferase has two isoforms with Mr 
= 39,000 ± 500 and 38,500 ± 500 designated a and fl, 
respectively as described later (Figures 15 and 16). 
B. validation of Zymography 
1. The gymoaraphlc In situ gel assay 
The monoADP-ribosyltransferase zymographic assay was 
originally described (19) as the detection of [P-32]ADP-
ribosylated histone that had precipitated in the region of the 
gel where ADP-ribosyltransferase was localized. Zymography is 
a method of choice when the presence of other components such 
as protein, lipid, or metals may interfere with the activity 
(19). The enzyme, isolated by electrophoresis, is essentially 
free from stimulation or interference from other components in 
a complex biological milieu. We characterized the zymographic 
assay more thoroughly than original report of the assay (19) 
to assure its accuracy for the detection of monoADP-
ribosyltransferase. Parameters studied included linearity, 
hydroxylamine sensitivity, inhibition by 3-aminobenzamide and 
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hlstone stimulation as well as a more thorough definition of 
the substrate. 
1 2 3 4 5 6 7 kDa 
Figure 5. Qualitative summary of the purification. Silver 
stained PAGE of fractions representing the six 
stages of purification. Identities and amounts of 
protein loaded were: lane 1, 15 K x g super (20 
ug); lane 2, 100 K x g pellet (22 ug), lane 3, 0.3 
% doc extract (12 ug); lane 4, DE-52 pool (10 ug); 
lane 5, concanavalin A eluate (5 ug); lane 6, 3ABA 
eluate (4 ug); and lane 7, Mr stds. 
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2. Linearity 
The zymographic reaction was linear with respect to time 
for up to .60 min, with a maximal reaction seen at 4 h as 
studied in the present investigation (Figure 6). 
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Figure 6 .  Time course of zymographic reaction. Gel slices, 
from the 38,000 - 39,000 Da region of lanes in 
which 11 ug protein (monoADP-ribosyl-transferase, 
con A eluate) was electrophoresed, incubated 
for the indicated times, fixed, washed and counted 
as described in "Methods." 
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3. HvdroxvlaiBine sensitivity 
Sensitivity of the linkage between ADP-rlbose and the 
acceptor to neutral hydroxylamlne is a criterion for the 
determination of what type of amino acid was ADP-rlbosylated 
(27). Cysteine specific ADP-ribosylation is relatively 
insensitive as are the nonenzymatlc Schlff basé reactions that 
can occur between the reducing end aldehyde of ADP-rlbose 
generated from hydrolyzed NAD and free amino groups. 
Arglnine specific ADP-ribosylation is determined by a partial 
(50%) loss of label by incubation with 0.5 H hydroxylamlne for 
1 h at 37'C. ADP-rlbosylated carboxyl groups, as in the poly-
ADP-rlbosyltransferases are completely labile to. 0.5 M 
hydroxylamlne. As shown in Figure 7, there is a time-
dependent release of 50% of the label from the hydroxylamlne 
treated auto-ADP-ribosylated protein as compared to the NaCl 
treated protein. This Indicates that the zymographic auto-
ADP-ribosylation occurs on arglnine residues. 
4. 3-aminoban*am4de inhibition 
The ADP-ribosyltransferase zymographic reaction was 
inhibited with 3-aminobenzamide, a known inhibitor of mono-
ADP-rlbosyltransferase in the mllllmolar range (29). Figure 8 
is a Dixon-Webb plot of the auto-ADP-ribosylatlon with 
variable concentrations of 3-aminobenzamlde (Kl = 14 mM). 
There was a nearly linear decrease in the labeling of enzyme 
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in the gel slices with increasing inhibitor concentration, 
indicating a specific inhibition of ADP-ribosyltransferase. 
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Figure 7. Hydroxylamine sensitivity. Zymographically reacted 
preparative-gel slices containing [P-32]ADP-
ribosylated transferase were electroeluted (20 ug) 
and incubated in 0.5 M NaCl (o) or 0.5 M neutral 
hydroxylamine ( • ) as described in "Methods." 
Panel k, autoradiogram; Panel B densitometry scans. 
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Figure 8. 3-aminobenzamide inhibition of zymography. 
Gel slices from the 38,000 - 39,000 Da region of 
lanes to which 11 ug protein.(monoADP-
ribosyltransferase, con A eluate) was 
electrophoresed, incubated in the zymographic 
reaction conditions with the indicated 
concentrations of 3-aminobenzamide for 4 h, fixed, 
washed and Cerenkov counted. Incorporation of 
[P-32] was plotted 1/cpm versus inhibitor 
concentration in a Dixon-Webb plot as described in 
"Methods." 
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5. ptimmstton 
The zymographlc auto-ADP-rlbosylatlon of membrane mono 
ADP-rIbosyItransferase was found to be stimulated by hlstone 
as shown in Figure 9 
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Figure 9. Histone stimulation. Gel Slices from the 38,000 -
39,000 Da region of lanes to which 11 ug protein 
(monoADP-ribosyltransferase, con A eluate) was 
electrophoresed, zymographically incubated in 
the indicated concentrations of histone, fixed, 
washed and counted as described in "Methods.". 
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6. Auto-ADP-ribo8vlation 
The notion of ADP-ribosylated histone precipitating in the 
region of the gel where the enzyme was present as originally 
described (19) was tentatively shown to be incorrect by the 
results presented in Figure 10. Gel slices incubated with the 
full complement of buffer components, including histone, were 
carried thorough the zymographic assay, electroeluted, and re-
electrophoresed (Figure 10, lane 1) with histone control in an 
adjacent lane (Figure 10, lane 2). The Mr = 38,000 - 39,000 
band was labeled as were some components at the tracking dye 
front (Figure 10, lane 3). No radioactive components were 
found corresponding to the molecular weight forms of the 
proteins in the histone preparation. The biochemical nature 
of the low molecular mass component at the tracking dye front 
was not positively identified but çould be residual [P-32] NAD 
or some ADP-ribose lost from the enzyme during the second 
electrophoretic step. The results from these findings suggest 
that the ADP-ribosyltransferase is auto-ADP-ribosylated in the 
presence of histone. 
7. Confirmation 
The identity of the Mr - 38,500 - 39,000 bands (a + fl 
forms) as mono-ADP-ribosyltransferase and the validity of the 
zymographic assay was positively confirmed by incubation of 
renatured enzyme in gel slices from the above Mr range with 2 
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mM DEA-BAG, 10 mM NAD, and 100 mM phosphate buffer, pH 7.5, 
for 0, 2 and 4 h. Reverse-phase HPLC analysis performed as 
described in "Experimental Procedures," confirmed the 
conversion of DEA-BAG to ADP-ribosylated DEA-BAG with an 
approximate specific activity about 10% that of the starting 
material, 
Figure 10. Auto-ADP-ribosylation. Zymographic gel slices from 
the 38,000 -39,000 region of several lanes contain­
ing a total of 60 ug protein (ADP-ribosyltrans,fer-
ase, con A eluate) were electroeluted (18 ug) and 
re-electrophoresed. Lane 1 is the silver stain of 
the re-electrophoresed sample, lane 2 is the silver 
stain of 5 ug histone (Sigma, type VIIIs), and lane 
3 is the autoradiogram of lane 1. The arrows de­
note the location of the 38,500 Da band. 
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Figure 11 shows the HPLC chronatpgrans obtained after 
incubations for A) Oh; B) 2 h; and C) 4 h. Product peaks 
eluted at retention times 16 and 17 min, internal standards 
eluted at 14.25 and 15 min, and unconverted substrate eluted 
at 20 to 25 min. Incubations carried out on other regions of 
the gel showed no enzymatic activity. 
C. Charaoterisation 
1. Sensitivity to reduction 
The zymographic assay was quite reproducible with regard 
to the pretreatment of the cholera toxin and muscle mono-ADP-
ribosyltransf erase with reducing agent. As shown in Figure 
12, cholera toxin displayed a marked enhancement of activity 
in the presence of fi-mercaptoethanol (lanes 2 and 4 with . 
and-without B-mercaptoethanol respectively). In contrast, the 
muscle mono-ADP-ribosyltransferase showed a marked decrease in 
activity with a fi-mercaptoethanol pretreatment (Figure 12, 
lanes 1 and 3 with and without B-mercaptoethanol respective­
ly) . Near overloading of the gel was necessary to detect a 
signal for the muscle transferase under reducing conditions. 
Under reducing conditions, the cholera toxin A subunit split 
into the catalytic A1 subunit Mr = 21,000 and the A2 subunit 
Mr - 7,000. No shift in Mr was detected for the muscle 
membrane ADP-ribosyltransferase with reduction, indicating a 
monomeric catalytic subunit. 
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Figure 11. DEA-BAG HPLC assay chromatograms of renatured gel 
slices. The reaction mixture was incubated for (A) 
0 h, (B) 2 h, and (C) 4 h as described in 
"Methods." The anomeric ADP-ribosylated DEA-BAG 
product peaks had retention times of 16 and 17 min 
(shown by arrow). Internal standards had 
retention times of 14.5 and 15 min. Unconverted 
DEA-BAG had a retention time of 20 - 23 min. 
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Figure 12. Zymography autoradiogran: 0-mexeaptoethanol 
pretreatment of cholera toxin A and membrane 
muscle ADP-ribosyltransferase. Lanes 1 and 3 were 
20 ug each of muscle membrane ADP-ribosyltransfer­
ase (con A eluate) with and withoutpretreatment 
in sample buffer containing 5 % 6-mercaptoethanol, 
respectively. Lanes 2 and 4 were and 5 ug cholera 
toxin A subunit with and without pretreatment in 
sample buffer containing 5% B-mercaptoethanol, 
respectively. 
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A time dependent loss of ADP-ribosyltransferase activity 
was monitored by the quantitative DEA-BAG HPLC assay as shown 
in Figure 13. Transferase was preincubated in 10 mM 
dithiothreitol for 0 to 6 hours followed by assay in 2 mM DEA-
BAG, 10 mM NAD and 100 mM phosphate, pH 7.5 and analysis by 
reversed phase HPLC as described in "Methods." Inclusion of 
NAD with the dithiothreitol provided a partial protection of 
inactivation. The results shown in Figures 12 and 13 indicate 
the likely presence of a buried intramolecular disulfide that 
is required for full activity. 
2. Zvmoaraphic summary of the last stages of the 
purification 
A qualitative summary of the last stages of the 
purification is shown in Figure 13. Panel A is the silver-
stained gel, and panel B is the autoradiogram of the same gel 
carried through the zymographic in situ mono-ADP-ribosyl-
transferase assay. Lanes 1 through 3 are the last three 
stages of purification. Near overloading of the mini-gel with 
crude fractions (earlier stages) allowed detection of just one 
ADP-ribosyltransferase band with the zymography when over­
exposed to the film with intensifying screens (data not 
shown). These procedures were employed to display the 
sensitivity and specificity of the zymographic assay used in 
this investigation. The purified enzyme (lane 3) migrated as 
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a single silver-stained protein band (panel A) which aligned 
perfectly with the zymographic signal as seen in panel B. The 
Mr (avg) = 39,000 ± 500. The purified protein could not be 
seen after coomassie staining and required silver-staining for 
visualization. 
3. Isefoms with two molecular weights 
An apparent doublet of active enzyme in the penultimate 
step of purification (con A eluate) was localized utilizing 
the zymographic assay and silver-stained gels. The two bands 
had Mr = 39,000 ± 500 and 38,500 ± 500 and were designated a 
and 6 respectively. The 3-aminobenzamide agarose column 
resolved the a and B forms almost entirely. As seen in Figure 
15, the 3-aminobenzamide fall through active band (lane 1) had 
a Mr = 38,500 ± 500 (fi) whereas the 3-amino-benzamide agarose 
retained fraction had a Mr = 39,000 ± 500 (a). Both forms 
could auto-ADP-ribosylate in the zymographic assay. 
4. ADP-ribosylhvdrolase conversion of a to fl 
The difference in Mr of 500 could be accounted for if the 
ADP-ribosyltransferase o was an endogenously auto-ADP-
ribosylated form of ADP-ribosyltransferase B because the 
molecular mass of ADP-ribose is 559. To test this theory, we 
treated the con A eluate (o + Û) with a partially purified 
ADP-ribosylhydrolase before electrophoresis and zymography. 
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Figure 13. Inactivation of AOF-ribosyltransferase by 
reduction. ADP-ribosyltransferase (27,000 U in 100 
ul) was preincubated at 30 oC in (É) buffer alone 
(100 mM phosphate, pH 7.5); (•} 10 mM NAD in 
buffer; (a) lo mM dithiothreitol in buffer; or 
(^) 10 mM dithiothreitol and 10 mM NAD in buffer. 
At the indicated times, aliguots were assayed as 
detailed in "Methods." 
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Figure 14. Zynographio summary of purification. Panel A, 
silver stained gel of fractions representing the 
last three stages of purification; Panel B, 
autoradiogram of the same gel carried through the 
zymographic assay as described in "Methods." 
Lane 1, DE-52 pool (10 pg); lane 2 ,  con A eluant 
(5 /ig) ; lane 3, 3ABA eluant (4 ug) . 
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Figure 15. Autoradlo.gram of zymographici analysis of ADP-
ribosyltransferase a and B. Lane 1 was the 3-
aminobenzamide agarose fall through (&, 10 ug) and 
lane 2 the eluant (a, 4 ug), carried through the 
zymography as described in "Methods." 
The results are shown with an autoradiogram of the 
zymographic assay in Figure 16. The average molecular mass of 
ADP-ribosyltransferase a + S decreased by about 500 daltons to 
a mass similar to that assigned as ADP-ribosyltransferase fi 
when incubated with ADP-ribosylhydrolase (Figure 16, lane 2). 
In addition to a shift in molecular mass, the ADP-
ribosyltransferase fl displayed a greater activity than the 
mixture of a and B as determined by scintillation counting. 
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Figure 16. Conversion of isoform a to 0: ADP-ribosyl-
hydrolase incubation with ADP-ribosyltransferase; 
lane 1 was ADP-ribosyltransferase (con A eluate, 12 
ug) incubated alone, lane 2 was ADP-ribosyltrans-
ferase (con A eluate, 12 ug) incubated with ADP-
ribosylhydrolase (5 ug, 493 U/mg) lane 3 was ADP-
ribosylhydrolase incubated alone before 
electrophoresis and zymography as described 
in "Methods." Scintillation counting of the gel 
slices were 236 cpm (lane 1), 1100 cpm (lane 2), 
and 130 cpm (lane 3). ADP-ribosyltransferase a and 
fi had Mr = 39,000 and 38,500, respectively. 
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5. ADP-riboflvltranaferaae la a glvcoprotaln 
ADP-rlbosyltransferase (10 ug), electrophoretlcally 
purified from 3-aminobenzamide fall through, was sent to Dr. 
Kevin Campbell's lab (Dept. of Physiology and Biophysics, Iowa 
City) for analysis. The sample was electrophoresed in a lane 
adjacent to dihydropyridine receptor, pure calseguestrin and 
triads, blotted to nitrocellulose and probed with horse radish 
peroxidase conjugated to concanavalin A. As shown in Figure 
17, transferase (mADPRT) was a positive signal as were the 
dihydropyridine receptor and triads. Pure calseguestrin, 
which is not reactive with concanavalin A, did not react. 
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Figure 17. Concanavalin A récognition of glycoprotein. 
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IV. DISCUSSION 
An integral membrane-associated arginine specific mono-
ADP-ribosyltransferase has been purified to k 95% homogeneity. 
We have determined some of its catalytic and structural prop­
erties making this the first report of the purification of the 
mammalian form of the enzyme. The specific activities of the 
purified a form, 1.9 um/min*mg, and fi-form, 6.0 umol/min.mg, 
are about 10 - 30 X higher than that for the mono-ADP-ribosyl-
transferase purified from hen liver nuclei, 0.197 um/min*mg 
(36); about the same as the cys-specific transferase purified 
from human erythrocyte, 8 umol/min.mg (4) and about 50 X less 
than that from turkey erythrocyte, 353 um/min*mg (5). The 
exact assays used to determine the enzymatic activities in the 
various studies differ and care should be taken in making 
close comparisons. 
Kinetic parameters were determined from secondary plots of 
double reciprocal plots (16). The Km values for the muscle 
monoADP-ribosyltransferase were found to be 1.2 mM for LAME 
and 0.56 mM for NAD. The Vmax was 40 umol/min/mg. The Km for 
NAD was about 80 times higher than that for ADP-ribosyltrans­
ferase from turkey erythrocyte (9), 8 times higher than 
transferase from hen liver nuclei (36) and 8.6 times higher 
than the cys-specific transferase from human erythrocyte. The 
Vmax for the turkey erythrocyte mono-ADP-ribosyltransferase, 
using agmatine as the co-substrate, was 31 umol/min/mg (9). 
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The Vnax for the cys-speclflc transferase was 34.5 umol/min.mg 
using cysteine methyl ester as the acceptor (4). 
The 645-fold purification relative to the microsomal 
fraction suggests a moderate abundance of the enzyme in the 
muscle microsome. This could reflect a physiological role in 
the regulation of Ca++ transport (36) in support of muscle 
contraction processes. The muscle enzyme is more abundant 
than the turkey erythrocyte ADP-ribosyltransferase which 
required a 544,000 fold purification (5) and the cys-specific 
transferase from human erythrocyte which required a 35,000 
fold purification (4). The mono-ADP-ribosyltransferase 
purified from hen liver nuclei (34) required a 640 fold 
purification relative to isolated nuclei, which suggests a 
similar abundance as the muscle ADP-ribosyltransferase. The 
low concentration of monoADP-ribosyltransferase in the 
erythrocyte may be due in part to the presence of hemoglobin, 
which constitutes 90 % of the solid mass of the erythrocyte 
(35). Until the physiological role is assigned to the various 
classes of endogenous ADP-ribosyltransferases, there is no 
assurance that the mammalian ADP-ribosyltransferase will 
resemble that from avian sources with respect to relative 
abundance, specific activity and regulation. 
The Mr = 38,500 - 39,000 ± 500 of the isozymes isolated in 
these studies was higher than the mono-ADP-ribosyltransferases 
isolated from erythrocyte Mr = 28,000 - 32,000 (1,4,5), 
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identified in Xenopus skeletal and heart muscle Mr = 32,000 
(18), or cholera toxin A1 subunit Mr - 21,000 (1)• The enzyme 
is glycosylated as determined by the complete binding of the 
horse radish peroxidase conjugated concanavalin A to transfer­
ase bound to nitrocellulose. It also displayed an inability 
to be visualized by Coomassie staining and required silver-
staining. The differences of Mr between the erythrocyte and 
skeletal muscle membrane ADP-ribosyltransferase may. be a 
function of the degree of glycosylation or the presence of a 
signal peptide dependent upon the biosynthetic route and the 
post-traAslational processing the enzyme undergoes prior to 
insertion into the target membrane (33). The muscle 
microsomal membrane preparation used in this investigation was 
prepared with 100,000 x g centrifugal force for pelleting of 
the homogenate after a low-speed centrifugation and filtra­
tion. These forces pellet membrane components from the plasma 
membrane, sarcoplasmic reticulum, and sarcolemma (23) . The 
two ADP-ribosyltransferase isoforms reported in this study 
could be from different subcellular locations. 
Closer inspection of the differences between the 3-
aminobenzamide agarose fractions revealed a subtle nature of 
the enzyme. Close to 80% of the activity did not bind to 6 
the 3-aminobenzamide agarose column. The remainder of the 
activity was bound to and eluted from the column with either 
25 mM 3-methoxybenzamide or 2 M KCl in the regeneration step. 
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Zymography of silver-stained gels revealed doublet bands at Mr 
= 39,000 and 38,500 ± 500. The 3-aminobenzamide agarose 
column resolved these two molecular weight forms and they were 
termed mono-ADP-ribosyltransferases a and S for the higher and 
lower Mr forms, respectively. 
Attempts to bind the 0 form to the 3-aminobenzamide column 
were unsuccessful, both before and after auto-ADPribosylation 
in solution. Although mono-ADP-ribosyltransferase was found 
to auto-ADP-ribosylate in the zymographic assay and in solu­
tion, the stoichiometry is thought to be > 1. Further studies 
on the conformation of ADP-ribosyltransferase a and /9 would 
help define the preferential binding of the a form to the 3-
aminobenzamide column. It could be that some specific factor 
such as ARF (31) or another membrane protein (32) is required 
for the auto-ADP-ribosylation to occur to produce the 
appropriate conformation. Alternatively, the auto-ADP-
ribosylation site in the a form may block the binding of some 
other protein that restricts binding to the 3ABA column. A 
58,000 Da protein, as determined by SDS-PAGE, was found to 
always co-elute with the 0 form in the 3ABA fall through 
fractions. This protein was positively identified as 
calseguestrin by N-terminal sequencing and western blotting 
(data not shown). If the auto-ADP-ribosylation site in the a 
form blocks the interaction with the 58,000 Da protein, which 
blocks binding to the 3ABA column, then this could explain 
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the binding of the a (auto-ADP-ribosylated) form of the 
transferase to the column. 
The turkey erythrocyte mono-ADP-ribosyltransferase is 
stimulated by histone (30) and this property is shared by the 
membrane muscle mono-ADP-ribosyltransferase auto-ADP-ribosyl-
ation. The relative dependence of isozymes a and 6 upon 
histone stimulation of activity towards exogenous substrates 
is under further investigation. The muscle membrane ADP-
ribosyltransferase was found to be inactivated by reducing 
agents. This was found to be in contrast to cholera toxin A 
subunit, which requires reduction for release of the free 
catalytic subunit. With reduction, the muscle ADP-ribosyl-
transferase demonstrated a marked drop in activity yet 
underwent no shift in Mr. This indicates that the catalytic 
subunit is a monomer, as shown with the other transferases 
(1,5,18,34) but must contain either an intramolecular 
disulfide or disulfide linkage with a very small molecule such 
as glutathione for full activity. The inactivatioh kinetics 
were very slow (T 1/2 > 1 Hr, Figure 13), indicating a 
relatively inaccessible site of reduction. This property of 
the membrane ADP-ribosyltransferase may be an indication of 
regulation by either the oxidation state or degree of S-
thiolation of the enzyme. 
It seems likely that many of the arginine specific 
transferases will demonstrate different substrate 
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specificities and biological functions. ADP-ribosylation of 
transducln by the arginlne specific transferase purified from 
turkey erythrocyte was shown to inhibit the GTPase activity of 
the G-proteln (34). This study indicated that the endogenous 
ADP-ribosyltransferases may play a critical role in the 
regulation of 6-protein mediated signal transduction. The 
specificity of the erythrocyte transferase towards transducln 
was found to be different from that of cholera toxin which 
does not inhibit the GTP binding activity of transducln as 
does the erythrocyte transferase (34). The metabolic role of 
the muscle membrane associated mono-ADP-rlbosyltransferase has 
not been clearly defined. One study (35) reported an NAD-
dependent suppression of Ca++-dependent ATPase in preparations 
containing both the ATPase and the ADP-ribosyltransferase 
which were partially purified from skeletal muscle sarco­
plasmic reticulum and reconstituted into vesicles. 
Since Ca++ transport plays a central role in muscle 
contraction, such regulation of the Ca++ ATPase by ADP-
ribosyltransferase may reflect a adrenergic or muscarinic 
signal transduction effector system. 
It is very likely that the membrane mono-ADP-ribosyl-
transferase serves some metabolic or signal transductional 
role since the ADP-ribosylhydrolase activity is also found in 
skeletal muscle. Strict regulation and substrate specificity 
of the enzyme is suspected and warranted because of the 
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resemblance of this enzyme to certain pathological toxins. 
This purified enzyme will provide a tool for further 
Investigation and understanding of the role of endogenous 
Intramembrane mono-ADP-rlbosyltransferase in signal 
transductlonal events. 
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